Diluted EPS came in at $-11.51.
Trailing eight quarters through Q3 2024
Common questions about AEON Biopharma's Q3 2024 earnings report.
AEON Biopharma (AEON) reported Q3 2024 earnings on November 13, 2024 before market open.
AEON Biopharma reported diluted EPS of $-11.51 for Q3 2024.
EPS beat the consensus estimate of $-11.51 by $0.00.
You can read the 10-Q periodic report (0001837607-24-000093) directly on SEC EDGAR. The filing index links above go to sec.gov.